Skip to content
Study details
Enrolling now

Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation

University of New Mexico
NCT IDNCT06940609ClinicalTrials.gov data as of Apr 2026
Phase

Phase 2

Target enrollment

60

Study length

about 4 years

Ages

18–80

Locations

1 site in NM

About this study

This trial is testing whether a type of rapid outpatient brain stimulation that uses magnetic fields, called accelerated intermittent theta burst stimulation (iTBS), can treat symptoms such as brain fog, depression, and anxiety in patients with Long COVID. The main questions it aims to answer are: Is iTBS effective and feasible for reducing Long COVID symptoms? We will measure these symptoms using the Symptom Burden Questionnaire. Are there changes in inflammatory brain chemicals associated with treatment with iTBS? We will be looking at levels of choline in the brain, which is thought to be related to inflammation.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Use accelerated intermittent theta burst stimulation
PhasePhase 2

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low6%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Devices

therapeutic

Body systems

Infectious